Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Fang Liu, Rong-Bin Lv, Yan Liu, Qian Hao, Shu-Jie Liu, Yuan-Yuan Zheng, Cui Li, Cheng Zhu & Min Wang. (2020) Salinomycin and Sulforaphane Exerted Synergistic Antiproliferative and Proapoptotic Effects on Colorectal Cancer Cells by Inhibiting the PI3K/Akt Signaling Pathway in vitro and in vivo. OncoTargets and Therapy 13, pages 4957-4969.
Read now
Read now
Yunxia Zhang, Jing Wang, Di Wu, Miao Li, Fenshu Zhao, Mulan Ren, Yunlong Cai & Jun Dou. (2018) IL-21-secreting hUCMSCs combined with miR-200c inhibit tumor growth and metastasis via repression of Wnt/β-catenin signaling and epithelial–mesenchymal transition in epithelial ovarian cancer. OncoTargets and Therapy 11, pages 2037-2050.
Read now
Read now
Xiangqi Meng, Jinquan Cai, Jichao Liu, Bo Han, Fei Gao, Weida Gao, Yao Zhang, Jinwei Zhang, Zhefeng Zhao & Chuanlu Jiang. (2017) Curcumin increases efficiency of γ-irradiation in gliomas by inhibiting Hedgehog signaling pathway. Cell Cycle 16:12, pages 1181-1192.
Read now
Read now
Articles from other publishers (24)
Oana Gabriela Trifanescu, Raluca Alexandra Trifanescu, Radu Iulian Mitrica, Diana Maria Bran, Georgia Luiza Serbanescu, Laurentiu Valcauan, Serban Andrei Marinescu, Laurentia Nicoleta Gales, Bogdan Cosmin Tanase & Rodica Maricela Anghel. (2023) The Female Reproductive Tract Microbiome and Cancerogenesis: A Review Story of Bacteria, Hormones, and Disease. Diagnostics 13:5, pages 877.
Crossref
Crossref
Jian Chen, Jia Liu, Shimin Chen, Ruijun Lai, Chuanchuan Zheng, Jialiang Lu, Xinshao Jiang, Feng He, Chengliang Yang, Kai Li, Kegong Xie, Yujin Tang & Liqiang Wang. (2022) Salinomycin alleviates osteoarthritis progression via inhibiting Wnt/β-catenin signaling. International Immunopharmacology 112, pages 109225.
Crossref
Crossref
ABDELKRIM ALILECHE. (2022) The IC-50-time evolution is a new model to improve drug responses consistency of large scale studies. F1000Research 11, pages 284.
Crossref
Crossref
Adrienn Sipos, Gyula Ujlaki, Edit Mikó, Eszter Maka, Judit Szabó, Karen Uray, Zoárd Krasznai & Péter Bai. (2021) The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Molecular Medicine 27:1.
Crossref
Crossref
Donald Rozario, Sammer Zeglam & Wolfram Siede. (2021) A Yeast Mutant Screen Identifies TORC and Lys63 Polyubiquitination Pathway Genes among Determinants of Sensitivity to the Cancer Stem Cell-Specific Drug Salinomycin. Journal of Analytical Oncology 9, pages 33-45.
Crossref
Crossref
Julia López de Andrés, Carmen Griñán-Lisón, Gema Jiménez & Juan Antonio Marchal. (2020) Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment. Journal of Hematology & Oncology 13:1.
Crossref
Crossref
Till Kaltofen, Valentina Preinfalk, Stephanie Schwertler, Patricia Fraungruber, Helene Heidegger, Theresa Vilsmaier, Aurelia Vattai, Bastian Czogalla, Doris Mayr, Sven Mahner, Udo Jeschke & Fabian Trillsch. (2020) Potential of platinum-resensitization by Wnt signaling modulators as treatment approach for epithelial ovarian cancer. Journal of Cancer Research and Clinical Oncology 146:10, pages 2559-2574.
Crossref
Crossref
Mahdi Zarei, Marie S. Jazi, Mahboubeh Tajaldini, Ayyoob Khosravi & Jahanbakhsh Asadi. (2020) Selective Inhibition of Esophageal Cancer Stem-like Cells with Salinomycin. Anti-Cancer Agents in Medicinal Chemistry 20:7, pages 783-789.
Crossref
Crossref
Marcin Michalak, Michał Stefan Lach, Michał Antoszczak, Adam Huczyński & Wiktoria Maria Suchorska. (2020) Overcoming Resistance to Platinum-Based Drugs in Ovarian Cancer by Salinomycin and Its Derivatives—An In Vitro Study. Molecules 25:3, pages 537.
Crossref
Crossref
Katerina Strouhalova, Magdalena Přechová, Aneta Gandalovičová, Jan Brábek, Martin Gregor & Daniel Rosel. (2020) Vimentin Intermediate Filaments as Potential Target for Cancer Treatment. Cancers 12:1, pages 184.
Crossref
Crossref
Ya‐Long Feng, Dan‐Qian Chen, Nosratola D. Vaziri, Yan Guo & Ying‐Yong Zhao. (2019) Small molecule inhibitors of epithelial‐mesenchymal transition for the treatment of cancer and fibrosis. Medicinal Research Reviews 40:1, pages 54-78.
Crossref
Crossref
Teeuwssen & Fodde. (2019) Wnt Signaling in Ovarian Cancer Stemness, EMT, and Therapy Resistance. Journal of Clinical Medicine 8:10, pages 1658.
Crossref
Crossref
Zonglei Mao, Yong Wu, Jin Zhou & Chungen Xing. (2019) Salinomycin reduces epithelial–mesenchymal transition-mediated multidrug resistance by modifying long noncoding RNA HOTTIP expression in gastric cancer cells. Anti-Cancer Drugs 30:9, pages 892-899.
Crossref
Crossref
Michał Antoszczak & Adam Huczyński. (2019) Salinomycin and its derivatives – A new class of multiple-targeted “magic bullets”. European Journal of Medicinal Chemistry 176, pages 208-227.
Crossref
Crossref
Carolina Sousa, Luís F. Gouveia, Bruna Kreutzer, Beatriz Silva-Lima, Retsepile E. Maphasa, Admire Dube & Mafalda Videira. (2019) Polymeric Micellar Formulation Enhances Antimicrobial and Anticancer Properties of Salinomycin. Pharmaceutical Research 36:6.
Crossref
Crossref
Li-Ya Zhang, Yuan Chen, Jue Jia, Xi Zhu, Yan He & Li-Ming Wu. (2019) MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1. Cancer Biomarkers 24:1, pages 31-42.
Crossref
Crossref
Michał Antoszczak. (2019) A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent. European Journal of Medicinal Chemistry 164, pages 366-377.
Crossref
Crossref
Björn L.D.M. Brücher & Ijaz S. Jamall. (2019) Undervalued ubiquitous proteins. 4open 2, pages 7.
Crossref
Crossref
Björn L.D.M. Brücher & Ijaz S. Jamall. (2019) Transition from normal to cancerous cell by precancerous niche (PCN) induced chronic cell-matrix stress. 4open 2, pages 14.
Crossref
Crossref
Jingcao Li, Lan Sun, Yan Liu, Hongjuan Yao, Shuang Jiang, YunzhuPu, Yajuan Li & Yingge Zhang. (2019) To reduce premature drug release while ensuring burst intracellular drug release of solid lipid nanoparticle-based drug delivery system with clathrin modification. Nanomedicine: Nanotechnology, Biology and Medicine 15:1, pages 108-118.
Crossref
Crossref
Vivek Kaushik, Juan Yakisich, Anil Kumar, Neelam Azad & Anand Iyer. (2018) Ionophores: Potential Use as Anticancer Drugs and Chemosensitizers. Cancers 10:10, pages 360.
Crossref
Crossref
Antoine Versini, Lou Saier, Fabien Sindikubwabo, Sebastian Müller, Tatiana Cañeque & Raphaël Rodriguez. (2018) Chemical biology of salinomycin. Tetrahedron 74:39, pages 5585-5614.
Crossref
Crossref
Wenjie Zhang, Feng Yu, Yu Wang, Yu Zhang, Lingxin Meng & Yuhua Chi. (2018) Rab23 promotes the cisplatin resistance of ovarian cancer via the Shh-Gli-ABCG2 signaling pathway. Oncology Letters.
Crossref
Crossref
Li Hou, Xiaofei Hou, Lijing Wang, Zenghui Li, Beibei Xin, Jing Chen, Xiaofei Gao & Haixia Mu. (2017) PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process. Cancer Biomarkers 21:1, pages 187-194.
Crossref
Crossref